Corrigendum: Editorial: Antiviral monoclonal antibody therapies

Saved in:
Bibliographic Details
Main Authors: Catalina Florez, Denise Haslwanter, Rohit K. Jangra
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2025.1558708/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832544901095489536
author Catalina Florez
Catalina Florez
Denise Haslwanter
Rohit K. Jangra
Rohit K. Jangra
Rohit K. Jangra
author_facet Catalina Florez
Catalina Florez
Denise Haslwanter
Rohit K. Jangra
Rohit K. Jangra
Rohit K. Jangra
author_sort Catalina Florez
collection DOAJ
format Article
id doaj-art-82fc3a57a6e347a39e0dd5b289a1fa20
institution Kabale University
issn 2235-2988
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj-art-82fc3a57a6e347a39e0dd5b289a1fa202025-02-03T08:47:16ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882025-02-011510.3389/fcimb.2025.15587081558708Corrigendum: Editorial: Antiviral monoclonal antibody therapiesCatalina Florez0Catalina Florez1Denise Haslwanter2Rohit K. Jangra3Rohit K. Jangra4Rohit K. Jangra5The Henry M. Jackson Foundation, Bethesda, MD, United StatesU.S Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United StatesDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, United StatesDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, United StatesCenter of Excellence for Emerging Viral Threats, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA, United StatesCenter for Applied Immunology and Pathological Processes, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA, United Stateshttps://www.frontiersin.org/articles/10.3389/fcimb.2025.1558708/fullmonoclonal AbsantiviralSARS-CoV-2COVIDbispecific Ab
spellingShingle Catalina Florez
Catalina Florez
Denise Haslwanter
Rohit K. Jangra
Rohit K. Jangra
Rohit K. Jangra
Corrigendum: Editorial: Antiviral monoclonal antibody therapies
Frontiers in Cellular and Infection Microbiology
monoclonal Abs
antiviral
SARS-CoV-2
COVID
bispecific Ab
title Corrigendum: Editorial: Antiviral monoclonal antibody therapies
title_full Corrigendum: Editorial: Antiviral monoclonal antibody therapies
title_fullStr Corrigendum: Editorial: Antiviral monoclonal antibody therapies
title_full_unstemmed Corrigendum: Editorial: Antiviral monoclonal antibody therapies
title_short Corrigendum: Editorial: Antiviral monoclonal antibody therapies
title_sort corrigendum editorial antiviral monoclonal antibody therapies
topic monoclonal Abs
antiviral
SARS-CoV-2
COVID
bispecific Ab
url https://www.frontiersin.org/articles/10.3389/fcimb.2025.1558708/full
work_keys_str_mv AT catalinaflorez corrigendumeditorialantiviralmonoclonalantibodytherapies
AT catalinaflorez corrigendumeditorialantiviralmonoclonalantibodytherapies
AT denisehaslwanter corrigendumeditorialantiviralmonoclonalantibodytherapies
AT rohitkjangra corrigendumeditorialantiviralmonoclonalantibodytherapies
AT rohitkjangra corrigendumeditorialantiviralmonoclonalantibodytherapies
AT rohitkjangra corrigendumeditorialantiviralmonoclonalantibodytherapies